ArticleSurgical case reports2025

Resectable Pancreatic Adenocarcinomas following Neoadjuvant Chemotherapy with Gemcitabine Plus S-1: Two Case Reports of Opposite Oncological Outcomes.

Masanobu Taguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.